Jelena Levi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jelena Levi has a total of 126 co-authors. Here are the top co-authors by number of shared publications:
- Youngho Seo
University of California
17 shared publications - Henry F. VanBrocklin
Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California
16 shared publications - Robert Richard Flavell
Department of Radiology and Biomedical Imaging University of California, San Francisco San Francisco California USA
14 shared publications - Alexander Dimitrios Colevas
Stanford University School of Medicine, Stanford, CA, USA
13 shared publications - Deepti Behl
Mayo Clinic
13 shared publications - Diwakar Davar
University of Pittsburgh Medical Center (UPMC) Hillman Cancer Center, Pittsburgh, Pennsylvania
13 shared publications
Latest Publications
- 15 October 2026
- Published by Society of Nuclear Medicine in Journal of Nuclear Medicine
[ 18 F]F-AraG PET Imaging of Immunometabolic Activity in Individuals Without Malignancy
[18F]F-AraG is a clinical-stage PET tracer in immuno-oncology that accumulates in activated T cells and tissues with high mitochondrial biogenesis. Characterizing its distribution in individuals without malignancy is essential for interpreting immunometabolic states relevant to cancer biology. Methods: Twenty adults without active malignancy underwent a single [18F]F-AraG PET/CT scan, with tracer uptake assessed in relation to clinical history, medications, and demographic and physiologic factors. Results: Bilateral brown adipose tissue activation was identified in 3 participants receiving potentially brown adipose tissue-activating medications, in the absence of cold exposure or fasting. One showed elevated vertebral bone marrow uptake, previously linked to poor survival in immune checkpoint inhibitor-treated lung cancer. One of 2 participants with breast implants showed asymmetric periimplant uptake. Posterior pulmonary uptake occurred in a subset of participants, often with prior respiratory conditions and thoracic lymph node uptake. Conclusion: Whole-body [18F]F-AraG PET captures diverse immunometabolic activity in individuals without malignancy, reflecting systemic processes that may influence cancer and treatment outcomes.
- 15 October 2026
- Published by Society of Nuclear Medicine in Journal of Nuclear Medicine
[ 18 F]F-AraG PET Imaging of Immunometabolic Activity in Individuals Without Malignancy
[18F]F-AraG is a clinical-stage PET tracer in immuno-oncology that accumulates in activated T cells and tissues with high mitochondrial biogenesis. Characterizing its distribution in individuals without malignancy is essential for interpreting immunometabolic states relevant to cancer biology. Methods: Twenty adults without active malignancy underwent a single [18F]F-AraG PET/CT scan, with tracer uptake assessed in relation to clinical history, medications, and demographic and physiologic factors. Results: Bilateral brown adipose tissue activation was identified in 3 participants receiving potentially brown adipose tissue-activating medications, in the absence of cold exposure or fasting. One showed elevated vertebral bone marrow uptake, previously linked to poor survival in immune checkpoint inhibitor-treated lung cancer. One of 2 participants with breast implants showed asymmetric periimplant uptake. Posterior pulmonary uptake occurred in a subset of participants, often with prior respiratory conditions and thoracic lymph node uptake. Conclusion: Whole-body [18F]F-AraG PET captures diverse immunometabolic activity in individuals without malignancy, reflecting systemic processes that may influence cancer and treatment outcomes.
- Open Access
- 14 August 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S2 from Mitochondrial Imaging Detects Early Cardiac Changes Following Cancer Immunotherapy
Effect of body size parameters and age on total cardiac mitochondria biogenesis activity (tCMA) and cardiac mitochondria biogenesis volume (CMBV).
- 14 August 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S2 from Mitochondrial Imaging Detects Early Cardiac Changes Following Cancer Immunotherapy
Effect of body size parameters and age on total cardiac mitochondria biogenesis activity (tCMA) and cardiac mitochondria biogenesis volume (CMBV).
- Open Access
- 14 August 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S4 from Mitochondrial Imaging Detects Early Cardiac Changes Following Cancer Immunotherapy
Comparison of SUVmax variability between harmonized and scanner-specific reconstructions for LV and RV across sites.
- 14 August 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S4 from Mitochondrial Imaging Detects Early Cardiac Changes Following Cancer Immunotherapy
Comparison of SUVmax variability between harmonized and scanner-specific reconstructions for LV and RV across sites.
- Open Access
- 14 August 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S3 from Mitochondrial Imaging Detects Early Cardiac Changes Following Cancer Immunotherapy
Representativeness of study participants.
- 14 August 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S3 from Mitochondrial Imaging Detects Early Cardiac Changes Following Cancer Immunotherapy
Representativeness of study participants.
- Open Access
- 14 August 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S7 from Mitochondrial Imaging Detects Early Cardiac Changes Following Cancer Immunotherapy
Box plot showing the distribution of TBR across sites and lesions, highlighting the wider variability observed in the measurements.
- 14 August 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S7 from Mitochondrial Imaging Detects Early Cardiac Changes Following Cancer Immunotherapy
Box plot showing the distribution of TBR across sites and lesions, highlighting the wider variability observed in the measurements.
- Open Access
- 14 August 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S5 from Mitochondrial Imaging Detects Early Cardiac Changes Following Cancer Immunotherapy
Comparison of SUVmean variability between harmonized and scanner-specific reconstructions for LV and RV across sites.
- 14 August 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S5 from Mitochondrial Imaging Detects Early Cardiac Changes Following Cancer Immunotherapy
Comparison of SUVmean variability between harmonized and scanner-specific reconstructions for LV and RV across sites.
- Open Access
- 14 August 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S2 from Mitochondrial Imaging Detects Early Cardiac Changes Following Cancer Immunotherapy
Demographics and cardiac [¹8F]F-AraG uptake parameters before and after immune checkpoint inhibitor therapy in patients with NSCLC.
- 14 August 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S2 from Mitochondrial Imaging Detects Early Cardiac Changes Following Cancer Immunotherapy
Demographics and cardiac [¹8F]F-AraG uptake parameters before and after immune checkpoint inhibitor therapy in patients with NSCLC.
- Open Access
- 14 August 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S1 from Mitochondrial Imaging Detects Early Cardiac Changes Following Cancer Immunotherapy
Flow diagram of the human cohort study.
- 14 August 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S1 from Mitochondrial Imaging Detects Early Cardiac Changes Following Cancer Immunotherapy
Flow diagram of the human cohort study.
- Open Access
- 14 August 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S6 from Mitochondrial Imaging Detects Early Cardiac Changes Following Cancer Immunotherapy
Correlation between TBR and SUVmax in healthy cohorts, demonstrating a strong positive relationship (R2 = 0.97).
- 14 August 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S6 from Mitochondrial Imaging Detects Early Cardiac Changes Following Cancer Immunotherapy
Correlation between TBR and SUVmax in healthy cohorts, demonstrating a strong positive relationship (R2 = 0.97).
- Open Access
- 14 August 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S3 from Mitochondrial Imaging Detects Early Cardiac Changes Following Cancer Immunotherapy
Uniform cardiac [¹8F]F-AraG uptake in a breast cancer survivor.
- 14 August 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S3 from Mitochondrial Imaging Detects Early Cardiac Changes Following Cancer Immunotherapy
Uniform cardiac [¹8F]F-AraG uptake in a breast cancer survivor.